A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT
Public ClinicalTrials.gov record NCT00751842. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, 3-Arm, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Impact of Diamyd on the Progression of Diabetes in Patients Newly Diagnosed With Type 1 Diabetes Mellitus (USA)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The intended purpose of this study was to determine whether Diamyd (rhGAD65 formulated in alum) is effective in preserving the body's own insulin producing capacity in patients recently diagnosed with type 1 diabetes. Based on results from other clinical trials with the study drug it was judged unlikely this study would meet the intended primary or secondary efficacy endpoints. Therefore the primary focus of this study was changed to ensure that safety data was available for at least 6 months following the last dose of active study drug. Thereafter the study was terminated.
Study identification
- NCT ID
- NCT00751842
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 331 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 10 Years to 20 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2008 (Type not available)
- Primary completion
- Mar 2012 (Actual)
- Completion
- Jul 2012 (Actual)
- Last update posted
- Oct 10, 2012
2008 – 2012
United States locations
- U.S. sites
- 43
- U.S. states
- 28
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona | Tucson | Arizona | 85724 | — |
| Arkansas Children's Hospital Research Institute | Little Rock | Arkansas | 72202 | — |
| Alex Endocrine Associates | Rogers | Arkansas | 72758 | — |
| Children's Hospital Orange County | Orange | California | 92868 | — |
| Rady Children's Hospital | San Diego | California | 92123 | — |
| Stanford University Medical Center | Stanford | California | 94305 | — |
| Barbara Davis Center for Childhood Diabetes | Aurora | Colorado | 80045 | — |
| Christina Care Research institute | Newark | Delaware | 19713 | — |
| University of Florida | Gainsville | Florida | 32610 | — |
| Nemours Children's Clinic | Jacksonville | Florida | 32207 | — |
| Miami Children's Hospital Research Institute | Miami | Florida | 33155 | — |
| University of South Florida | Tampa | Florida | 33606 | — |
| Atlanta Diabetes Associates | Atlanta | Georgia | 30309 | — |
| Rocky Mountain Diabetes and Osteoporosis Center | Idaho Falls | Idaho | 83404 | — |
| University of Iowa Hospitals and Clinicals | Iowa City | Iowa | 52242 | — |
| Mid America Diabetes Associates | Wichita | Kansas | 67211 | — |
| University of Kentucky College of Medicine | Lexington | Kentucky | 40536 | — |
| University of Louisville Research Foundation | Louisville | Kentucky | 40202 | — |
| Children's Hospital | New Orleans | Louisiana | 70118 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 21201 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| UMass Memorial Medical Center | Worcester | Massachusetts | 01655 | — |
| University of Michigan Health System | Ann Arbor | Michigan | 48109 | — |
| Alzohaili Medical Consultants | Dearborn | Michigan | 48126 | — |
| The Children's Mercy Hospital | Kansas City | Missouri | 64108 | — |
| St. Louis Children's Hospital | St Louis | Missouri | 63110 | — |
| Creighton Diabetes Center | Omaha | Nebraska | 68131 | — |
| Kathryn Eckert | Reno | Nevada | 89502 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Morristown Memorial Hospital | Morristown | New Jersey | 07962 | — |
| Winthrop University Hospital | Mineola | New York | 11501 | — |
| Naomi Berrie Diabetes Center of Columbia University | New York | New York | 10032 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| SUNY Institute for Human Performance | Syracuse | New York | 13210 | — |
| Children's Hospital Medical Center of Akron | Akron | Ohio | 44308 | — |
| University of Oklahoma, Schustermann Center Clinic | Tulsa | Oklahoma | 74135 | — |
| Children's Hospital of Pittsburgh of UPMC | Pittsburgh | Pennsylvania | 15224 | — |
| Regional Medical Clinic - Endocrinology | Rapid City | South Dakota | 57701 | — |
| LeBonheur Children's Medical Center | Memphis | Tennessee | 38103 | — |
| Cook Children's Medical Center | Fort Worth | Texas | 76104 | — |
| CHRISTUS Santa Rosa Children's Hospital | San Antonio | Texas | 78207 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23219 | — |
| Benaroya Research Institute | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00751842, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 10, 2012 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00751842 live on ClinicalTrials.gov.